Using samples from both endemic and non-endemic areas, we found that an existing dengue RDT, the SD BIOLINE Dengue IgG/IgM RDT, performed poorly when used as a screening assay for DENV serostatus in healthy subjects. This evidence concerns the gene CD40LG and dengue disease.